Published in J Biol Chem on October 05, 1985
Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin. J Cell Biol (1987) 1.68
Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent. J Cell Biol (1989) 1.54
Primary structure of human plasma fibronectin. Characterization of a 38 kDa domain containing the C-terminal heparin-binding site (Hep III site) and a region of molecular heterogeneity. Biochem J (1987) 1.33
Tissue-specific splicing pattern of fibronectin messenger RNA precursor during development and aging in rat. J Cell Biol (1991) 1.27
Interaction of heparin with fibronectin and isolated fibronectin domains. Biochem J (1990) 1.20
Interaction of the small proteoglycan decorin with fibronectin. Involvement of the sequence NKISK of the core protein. Biochem J (1991) 0.95
Models of fibronectin. EMBO J (1987) 0.94
Dissection of the osteogenic effects of laminin-332 utilizing specific LG domains: LG3 induces osteogenic differentiation, but not mineralization. Exp Cell Res (2008) 0.83
Novel folate binding protein-1 interactions in embryonic orofacial tissue. Life Sci (2010) 0.75
Quantitative proteomics reveals altered expression of extracellular matrix related proteins of human primary dermal fibroblasts in response to sulfated hyaluronan and collagen applied as artificial extracellular matrix. J Mater Sci Mater Med (2012) 0.75
Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res (2000) 10.78
Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science (1992) 9.01
Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry (1976) 6.00
Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase. Proc Natl Acad Sci U S A (1983) 5.50
Single-chain antigen-binding proteins. Science (1988) 5.29
Role of phosphorylation in p34cdc2 activation: identification of an activating kinase. Mol Biol Cell (1992) 4.17
Plant diversity enhances ecosystem responses to elevated CO2 and nitrogen deposition. Nature (2001) 3.92
Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med (1996) 3.74
The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol (1998) 3.65
Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels. Neuron (2001) 3.37
Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science (1975) 3.12
Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (1976) 2.85
The effect of ethnicity on physician estimates of pain severity in patients with isolated extremity trauma. JAMA (1994) 2.77
The Pumilio RNA-binding domain is also a translational regulator. Mol Cell (1998) 2.68
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63
Thermodynamic analysis of the folding of the streptococcal protein G IgG-binding domains B1 and B2: why small proteins tend to have high denaturation temperatures. Biochemistry (1992) 2.56
Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med (1992) 2.55
Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol (1994) 2.50
Genomic imprinting in an Angelman and Prader-Willi translocation family. Lancet (1991) 2.41
Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol (2001) 2.40
Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J (1987) 2.31
Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res (1999) 2.25
Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science (1999) 2.21
Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med (1983) 2.18
Biochemical characterization of a second family of human Ia molecules, HLA-DS, equivalent to murine I-A subregion molecules. J Exp Med (1982) 2.15
The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem (1997) 2.09
Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci U S A (1980) 2.00
Impact of inter-physician communication on the effectiveness of medical consultations. Am J Med (1983) 1.98
Microsequence analysis of peptides and proteins. II. Separation of amino acid phenylthiohydantoin derivatives by high-performance liquid chromatography on octadecylsilane supports. Anal Biochem (1982) 1.95
Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev (2006) 1.93
Nearest neighbor analysis of heparin: identification and quantitation of the products formed by selective depolymerization procedures. Biochemistry (1976) 1.90
Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family. Proc Natl Acad Sci U S A (1987) 1.86
Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nat Biotechnol (1997) 1.85
A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections. J Neurosci Methods (1999) 1.84
Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab (1995) 1.84
Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel. J Biol Chem (1998) 1.83
Isolation and sequence of an active-site peptide containing a catalytic aspartic acid from two Streptococcus sobrinus alpha-glucosyltransferases. J Biol Chem (1991) 1.81
Characterization of Torpedo californica acetylcholine receptor: its subunit composition and ligand-binding properties. Cold Spring Harb Symp Quant Biol (1976) 1.81
Numerical selection of optimal tumor imaging agents with application to engineered antibodies. Cancer Biother Radiopharm (2001) 1.81
CEA-related antigens: molecular biology and clinical significance. Crit Rev Oncol Hematol (1985) 1.79
A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol (1989) 1.73
A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem (1981) 1.70
Hormone-sensitive lipase: sequence, expression, and chromosomal localization to 19 cent-q13.3. Science (1988) 1.69
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci U S A (2000) 1.69
Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J Cell Biol (1987) 1.68
Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res (1996) 1.67
Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem (2000) 1.66
Cloning of Drosophila choline acetyltransferase cDNA. Proc Natl Acad Sci U S A (1986) 1.65
Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci U S A (1987) 1.63
Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett (1988) 1.61
Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem (1984) 1.61
Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. Br J Anaesth (2006) 1.60
Lack of specificity of endoglin expression for tumor blood vessels. Int J Cancer (2001) 1.60
Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci (1987) 1.60
Ten commandments for effective consultations. Arch Intern Med (1983) 1.59
Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut (2002) 1.57
Human apolipoprotein B: partial amino acid sequence. FEBS Lett (1984) 1.54
Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature (1978) 1.52
Immune response to blood transfusion invery-low-birthweight infants. Transfusion (2000) 1.51
The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer (1994) 1.51
Elution of fibronectin proteolytic fragments from a hydroxyapatite chromatography column. A simple procedure for the purification of fibronectin domains. Eur J Biochem (1985) 1.51
Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients. Cancer (1994) 1.50
Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure. J Perinatol (2013) 1.49
A case of tetramine poisoning: a lethal rodenticide. Hong Kong Med J (2005) 1.49
High diversity and widespread occurrence of mitotic spore mats in ectomycorrhizal Pezizales. Mol Ecol (2012) 1.49
An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA. Bioconjug Chem (2001) 1.48
Microsequence analysis of peptides and proteins. V. Design and performance of a novel gas-liquid-solid phase instrument. Anal Biochem (1985) 1.48
Requirement for the L-type Ca(2+) channel alpha(1D) subunit in postnatal pancreatic beta cell generation. J Clin Invest (2001) 1.46
Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments. Bioconjug Chem (2001) 1.44
Identification and localization of amino acid substitutions between two phenobarbital-inducible rat hepatic microsomal cytochromes P-450 by micro sequence analyses. Proc Natl Acad Sci U S A (1983) 1.43
Association of HLA-DRw4 with rheumatoid arthritis in black and white patients. Arthritis Rheum (1980) 1.42
Expression of emmprin by oral squamous cell carcinoma. Int J Cancer (2000) 1.42
Ligand-induced conformation changes in Torpedo californica membrane-bound acetylcholine receptor. Biochemistry (1978) 1.41
Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection. Pediatrics (1992) 1.40
The impact of total antioxidant capacity on pulmonary function in asthma patients. Int J Tuberc Lung Dis (2012) 1.40
[Euthanasia. An attempt to explain and define limits of the concept]. Tidsskr Nor Laegeforen (1997) 1.39
Assessing incidence rates and secular trends in nonmelanocytic skin cancer: which method is best? J Cutan Med Surg (1998) 1.38
Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc Natl Acad Sci U S A (1989) 1.38
Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F. J Cell Sci (1999) 1.38
Microsequence analysis of peptides and proteins. I. Preparation of samples by reverse-phase liquid chromatography. Anal Biochem (1982) 1.37
Measurement of two- and three-nucleon short-range correlation probabilities in nuclei. Phys Rev Lett (2006) 1.37
Transformed human cells release different fibronectin variants than do normal cells. J Cell Biol (1986) 1.37
Reversible drug-induced parkinsonism. Clinicopathologic study of two cases. Arch Neurol (1982) 1.36
Characterization of a cDNA clone for the nonspecific cross-reacting antigen (NCA) and a comparison of NCA and carcinoembryonic antigen. J Biol Chem (1988) 1.36
Generation of antibody activity from immunoglobulin polypeptide chains produced in Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.36
Isolation of a tryptic fragment containing the collagen-binding site of plasma fibronectin. J Biol Chem (1979) 1.35